| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $116.3M | — | +9.5% |
| Cost of Revenue | $94.2M | — | +15.4% |
| Gross Profit | $22.1M | — | -10.0% |
| R&D Expense | $5.3M | — | +20.2% |
| SG&A Expense | $36.7M | — | +37.0% |
| Operating Income | -$110.5M | — | -1565.9% |
| Interest Expense | $2.9M | — | -58.9% |
| Pre-tax Income | -$115.0M | — | -781.9% |
| Income Tax | -$110K | — | +91.6% |
| Net Income | -$114.8M | — | -879.1% |
| EPS (Basic) | -$1.51 | — | -1158.3% |
| EPS (Diluted) | -$1.51 | — | -1158.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $655.7M | +303.3% | — |
| Accounts Receivable | $3.9M | -65.9% | — |
| Inventory | $34.2M | +82.5% | — |
| Current Assets | $811.7M | +163.7% | — |
| Total Assets | $2.05B | +38.9% | — |
| Current Liabilities | $146.9M | -23.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$84.5M | — | -6.2% |
| Capital Expenditures | $2.1M | — | +83.1% |
| Investing Cash Flow | -$11.1M | — | -201.6% |
| Financing Cash Flow | $588.7M | — | — |
| Free Cash Flow | -$86.6M | — | -7.4% |
| Long-term Debt | $147.9M | -0.6% | — |
| Total Liabilities | $326.7M | -29.7% | — |
| Stockholders' Equity | $1.72B | +98.5% | +125.3% |